650 related articles for article (PubMed ID: 23280316)
1. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
5. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.
Christensen LL; Holm A; Rantala J; Kallioniemi O; Rasmussen MH; Ostenfeld MS; Dagnaes-Hansen F; Øster B; Schepeler T; Tobiasen H; Thorsen K; Sieber OM; Gibbs P; Lamy P; Hansen TF; Jakobsen A; Riising EM; Helin K; Lubinski J; Hagemann-Madsen R; Laurberg S; Ørntoft TF; Andersen CL
PLoS One; 2014; 9(6):e96767. PubMed ID: 24892549
[TBL] [Abstract][Full Text] [Related]
6. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
8. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
[TBL] [Abstract][Full Text] [Related]
9. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
10. miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer.
Zhu X; Ma SP; Yang D; Liu Y; Wang YP; Lin T; Li YX; Yang SH; Zhang WC; Wang XL
Cell Physiol Biochem; 2018; 51(4):1969-1981. PubMed ID: 30513513
[TBL] [Abstract][Full Text] [Related]
11. Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.
Jung CK; Jung SH; Yim SH; Jung JH; Choi HJ; Kang WK; Park SW; Oh ST; Kim JG; Lee SH; Chung YJ
Oncotarget; 2016 May; 7(22):32902-15. PubMed ID: 27096956
[TBL] [Abstract][Full Text] [Related]
12. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y
Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161
[TBL] [Abstract][Full Text] [Related]
13. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.
Qu X; Yang L; Shi Q; Wang X; Wang D; Wu G
Pathol Res Pract; 2018 Dec; 214(12):1974-1979. PubMed ID: 30262429
[TBL] [Abstract][Full Text] [Related]
15. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway.
Hua B; Li Y; Yang X; Niu X; Zhao Y; Zhu X
Biomed Pharmacother; 2020 May; 125():109994. PubMed ID: 32092817
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
[TBL] [Abstract][Full Text] [Related]
20. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M
Oncology; 2016; 90(4):221-31. PubMed ID: 26999740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
